Scrip
28 January 2010
Nancy Faigen
A federal judge has handed
Teva Pharmaceutical Industries a win in ruling that
Merck & Co's US patent No 5,260,291 for the brain cancer drug Temodor (temozolomide) – the only Orange Book-listed patent – is unenforceable due to "prosecution laches and inequitable conduct",...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Teva seeks to add more patents to US suit against Momenta/Sandoz on Copaxone
- Apotex seeks declaratory verdict related to generic Aricept in US
- US PTO re-examines Singulair patent after online community searches for prior art
- Mylan sued over plans for Vytorin generic, and claims first-filer status
COMMENT
Other Informa Comment
EVENTS
22 March 2010
London, UK
12 April 2010
Orlando, Florida
13 April 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
